全球即時血糖監測市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，照護現場將從 2025 年的 40.9 億美元成長至 65 億美元，2026 年至 2034 年的複合年成長率為 5.26%。

全球照護現場血糖監測市場正經歷顯著成長，這主要得益於糖尿病盛行率的上升和快速診斷解決方案需求的增加。即時血糖照護現場設備能夠實現即時血糖監測，從而支援及時的臨床決策和有效的疾病管理。人們對自我管理和預防性醫療保健意識的提高，正在推動即時血糖監測設備在醫院和居家照護中的應用。

攜帶式血糖儀、連續血糖監測系統和智慧型手機連接檢測設備的科技進步是成長要素。遠端醫療服務和遠端患者監護的擴展進一步刺激了市場需求。政府推廣糖尿病篩檢和管理計畫的措施也促進了市場成長。人口老化和久坐的生活方式加劇了全球糖尿病負擔。

未來，人工智慧 (AI) 與雲端資料管理系統的融合有望提升血糖監測儀的精準度和連接性。新興經濟體由於醫療服務覆蓋範圍的擴大和健康意識的增強，將帶來巨大的成長機會。持續創新，致力於提升產品的便利性和可負擔性，將有助於其長期普及應用。隨著慢性病管理日益受到重視，市場預計將持續保持強勁成長動能。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球即時血糖監測市場：依產品類型分類

• 市場分析、洞察與預測
• 採血筆和條帶
• 血糖儀

第5章 全球即時血糖監測市場：依應用領域分類

• 市場分析、洞察與預測
• 1型糖尿病
• 2型糖尿病

第6章 全球即時血糖監測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和診所
• 居家醫療環境
• 其他

第7章 全球即時血糖監測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Prodigy Diabetes Care LLC
  • Ascensia Diabetes Care Holdings AG
  • ACON Laboratories Inc
  • EKF Diagnostics Holdings Plc
  • Trividia Health Inc
  • Platinum Equity Advisors LLC
  • Abbott Laboratories
  • Nipro
  • F. Hoffmann-La Roche Ltd
  • Nova Biomedical Corporation

The Point-of-Care Glucose Testing Market size is expected to reach USD 6.50 Billion in 2034 from USD 4.09 Billion (2025) growing at a CAGR of 5.26% during 2026-2034.

The Global Point-of-Care Glucose Testing Market is witnessing significant growth driven by the rising prevalence of diabetes and increasing demand for rapid diagnostic solutions. Point-of-care devices enable immediate glucose monitoring, supporting timely clinical decisions and effective disease management. Growing awareness about self-monitoring and preventive healthcare is encouraging adoption among both hospital settings and home-care users.

Key growth drivers include technological advancements in portable glucose meters, continuous glucose monitoring systems, and smartphone-integrated testing devices. The expansion of telehealth services and remote patient monitoring has further boosted demand. Government initiatives promoting diabetes screening and management programs are also strengthening market expansion. Increasing geriatric population and sedentary lifestyles are contributing to the growing burden of diabetes worldwide.

In the future, integration of artificial intelligence and cloud-based data management systems is expected to enhance accuracy and connectivity of glucose testing devices. Emerging economies will provide substantial growth opportunities due to expanding healthcare access and rising health awareness. Continuous innovation aimed at improving convenience and affordability will support long-term adoption. As chronic disease management becomes a priority, the market is set for sustained and dynamic growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Lancing Devices and Strips
• Blood-Glucose Meter

By Application

• Type-1 Diabetes
• Type-2 Diabetes

By End User

• Hospitals and Clinics
• Home Care Settings
• Others

COMPANIES PROFILED

• Prodigy Diabetes Care LLC, Ascensia Diabetes Care Holdings AG, ACON Laboratories Inc, EKF Diagnostics Holdings plc, Trividia Health Inc, Platinum Equity Advisors LLC, Abbott Laboratories, Nipro, F HoffmannLa Roche Ltd, Nova Biomedical Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Lancing Devices and Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood-Glucose Meter Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Type-1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type-2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POINT-OF-CARE GLUCOSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Prodigy Diabetes Care LLC
  • 9.2.2 Ascensia Diabetes Care Holdings AG
  • 9.2.3 ACON Laboratories Inc
  • 9.2.4 EKF Diagnostics Holdings Plc
  • 9.2.5 Trividia Health Inc
  • 9.2.6 Platinum Equity Advisors LLC
  • 9.2.7 Abbott Laboratories
  • 9.2.8 Nipro
  • 9.2.9 F. Hoffmann-La Roche Ltd
  • 9.2.10 Nova Biomedical Corporation